Transgenic pig livers expressing complement regulating proteins: The Nextran collaboration between DNXX and Baxter received FDA clearance to begin a Phase I tri

The transgenic livers will be used as an ex vivo temporary organ support system until a patient's native liver recovers function or a donor organ is available.

The livers are engineered to express human complement regulatory proteins, which may prevent the patient's complement system from destroying the animal organ. ...